Skip to main content
Fig. 7 | Lipids in Health and Disease

Fig. 7

From: A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma

Fig. 7

Clinical sample verification. (A) Microscopic images illustrating immunohistochemical staining for RAN, MECR, and ARSK in lymph node sections from both controls and DLBCL patients. Both images were captured at 400× magnification. The horizontal bar on the right demarcates the region displaying positive signal expression of RAN, MECR, and ARSK in the lymph node sections between these two groups. Scale bar corresponds to 200 pixels. ***P < 0.001; **P < 0.01; *P < 0.05. (B-C) Selected immunofluorescent photograph depicting the expression of RAN, MECR, and ARSK alongside the marker for lymphoma cell (CD20 in B) or the T cell (CD3 in C) in lymph node sections obtained from DLBCL patients. DAPI was utilized for nuclear staining (bar = 500 pixels)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X